Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ADTX - Aditxt stock surges 61% on positive preclinical toxicity study of its psoriasis drug candidate

ADTX - Aditxt stock surges 61% on positive preclinical toxicity study of its psoriasis drug candidate

ADiTx Therapeutics Inc.

  • Aditxt ( NASDAQ: ADTX ) said on Friday that it completed a toxicology study that indicated the safety of its immunotherapeutic technology drug ADI-100, to treat rejection of transplanted organs, skin allografting, autoimmune diseases and allergies.
  • ( ADTX ) stock surged 61% before the bell.
  • The company said that the result will provide help when the company files an Investigational New Drug ( IND ) application with the regulatory agencies.

For further details see:

Aditxt stock surges 61% on positive preclinical toxicity study of its psoriasis drug candidate
Stock Information
Company Name: ADiTx Therapeutics Inc.
Stock Symbol: ADTX
Market: NASDAQ
Website: aditxt.com
Menu
ADTX ADTX Quote ADTX Short ADTX News ADTX Articles ADTX Message Board
Get ADTX Alerts

News, Short Squeeze, Breakout and More Instantly...